Identification and Evaluation of Safety Signals of Drugs Currently under Development Using a Limited Data Set
A recent increase in the number of safety signals of varying quality being submitted to the national and industry databases calls for the development of formalized search and analysis algorithms. The aim of the study was to develop an approach to identification and evaluation of safety signals in th...
Saved in:
Main Authors: | B. K. Romanov, N. I. Zykova, R. N. Alyautdin, Yu. V. Olefir |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/165 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disproportionality analysis and risk factor assessment of drug-associated thyroid dysfunction adverse events: a study based on the FAERS database
by: Zhifang Wang, et al.
Published: (2025-07-01) -
Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01) -
Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database
by: Yating An, et al.
Published: (2025-07-01) -
Age-stratified pharmacovigilance of azithromycin: a multimethod signal detection analysis in the FAERS database
by: Zhenpo Zhang, et al.
Published: (2025-12-01) -
Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database
by: Juan Su, et al.
Published: (2025-07-01)